Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Veritas Intercontinental logo — 🧬Sequencing your genome is the first step in a life-changin...

Veritas Intercontinental

🧬Sequencing your genome is the first step in a life-changing journey | Get more info: www.veritasint.com

Founded 2018 Spain Spain 68 employees Series A Total: $25.00M Biotechnology, Life Sciences

General Information

Company Name Veritas Intercontinental
Founded Year 2018
Location Spain Spain
Founders / Decision Makers
Team member Team member
Employees 68
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Veritas Intercontinental. To contact Veritas Intercontinental, visit veritasint.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Veritas Intercontinental compare?

A PDF of Veritas Intercontinental and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Veritas Intercontinental soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Veritas Intercontinental

Veritas Intercontinental, a biotechnology and life sciences startup founded in 2018 in Spain, is dedicated to utilizing genetic and genomic diagnostics to enhance and extend lives. The company's global portfolio encompasses preventive medicine, perinatal medicine, and genomic diagnostic services. Their slogan, "🧬Sequencing your genome is the first step in a life-changing journey," reflects their commitment to leveraging science and global resources for the betterment of individuals' health. In March 2022, Veritas announced its integration with LetsGetChecked, a global healthcare solutions company based in Dublin and New York. This strategic move aims to further the reach and impact of Veritas' offerings. The most recent significant development for the company was a €5.00M Series A investment on July 5, 2020, from a consortium of investors including Amadeus Capital Partners, Stemar Capital, Charme Capital Partners, and Javier de Echevarría. Veritas Intercontinental prioritizes collaboration with healthcare providers, governments, and local communities to make genetic and genomic medicine accessible and affordable on a global scale. For more information, interested individuals can visit their website: www.veritasint.com.

Business keywords: genetic diagnostics, genomic diagnostics, preventive medicine, perinatal medicine, healthcare solutions, whole genome sequencing, whole exome sequencing, clinical diagnostics, next generation sequencing, consumer genetics, hereditary cancer diagnostics

Services & Products

1
1
1

Target Customers

1 1 1

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €5.00M 4
Amadeus Capital Partners Stemar Capital Charme Capital Partners
Amadeus Capital Partners, Stemar Capital +2
05 Jul 2020
Series A $20.00M 2
Amadeus Capital Partners Charme Capital Partners
Amadeus Capital Partners, Charme Capital Partners
14 Jul 2018

Veritas Intercontinental Alternatives & Competitors

View All Alternatives
Veritas Intercontinental vs
Genoks Genetik Hastalıklar Değerlendirme Merkezi
Genoks Genetik Hastalıklar Değerlendirme Merkezi Turkey

Genlerinize Işık Tutuyoruz!

71 employees
Biotechnology, Life Sciences
Compare Veritas Intercontinental vs Genoks Genetik Hastalıklar Değerlendirme Merkezi
Veritas Intercontinental vs
Variantyx
Variantyx United States

Variantyx is a technology-driven precision medicine company providing state-of-the-art genomic testi...

Series D
221 employees
Biotechnology, Health Care
Compare Veritas Intercontinental vs Variantyx
Veritas Intercontinental vs
Polgen Biyoteknoloji
Polgen Biyoteknoloji Turkey

Advanced molecular diagnostics, genetic testing, next-generation sequencing, and bioinformatics serv...

3 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Veritas Intercontinental

🧬Sequencing your genome is the first step in a life-changing journey | Get more info: www.veritasint.com
Veritas Intercontinental was founded in 2018.
Veritas Intercontinental is headquartered in Spain.
Veritas Intercontinental operates in Biotechnology and Life Sciences. Its work centres on genetic diagnostics, genomic diagnostics, preventive medicine and perinatal medicine. Its customers include 1.
Veritas Intercontinental has approximately 68 employees.
Veritas Intercontinental has completed 2 funding rounds, raising a total of $25.00M. The latest funding stage is Series A.
Veritas Intercontinental offers: 1, 1, 1.
Top alternatives and competitors to Veritas Intercontinental include Genoks Genetik Hastalıklar Değerlendirme Merkezi, Variantyx, Polgen Biyoteknoloji, Nurture Genomics, Macrogen Europe. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Veritas Intercontinental and Genoks Genetik Hastalıklar Değerlendirme Merkezi are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Veritas Intercontinental, https://bouncewatch.com/company/veritas-intercontinental, updated 25 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes